|
| SARS-COV-2 NSP7&NSP8 Protein (LTP10697) |
|
| LTP10697 |
|
| 100ug |
|
|
$519 In stock |
| The crystal structure of the metabolite of remdesivir (Monophosphate of GS-441524) and NSP12-NSP8-NSP7 of SARS CoV-2 virus was recently reported. The crystal structures of ADP-Ribose or AMP and NSP3 of SARS CoV-2 virus were also released, recently. The crystal structure of NSP3 of SARS CoV-2 virus as an alternative binding site of AMP or ADP-ribose to treat COVID-19. |
| SARS-COV-2 NSP7&NSP8 Protein is expressed from E.coil with His tag at the C-terminal. It contains Ser1-Gln83(NSP7)&Ala1-Gln198(NSP8). |
|
| NSP7&NSP8 |
|
| SARS-CoV-2 |
|
| YP_009725303.1(NSP7)&YP_009725304.1(NSP8) |
|
| Ser1-Gln83(NSP7) & Ala1-Gln198(NSP8) |
|
| The protein has a predicted MW of 32.8 kDa same as Tris-Bis PAGE result. |
|
| 0 |
|
| C-His |
|
| E.coli |
|
| > 95% as determined by Tris-Bis PAGE |
|
| Less than 1EU per ug by the LAL method. |
|
| Lyophilized from 0.22 um filtered solution in 20mM Tris, 150mM Nacl, 200mM Arginine (pH 8.2). Normally 8% trehalose is added as a protectant before lyophilization. |
|
| Reconstituted protein stable at -80 C for 12 months, 4 C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
|
| Shipped at ambient temperature. |
|
| Centrifuge tubes before opening. Reconstituting to a concentration of more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water. |
|
|  |
